Generics makers appeal ruling on patents for Pozen's Treximet

09/8/2011 | MedCityNews.com

Alphapharm, Dr. Reddy's Laboratories and Par Pharmaceutical appealed a court decision that upholds patents covering Pozen's migraine drug Treximet. The ruling blocks FDA approval of the firms' generic versions before patent expiration.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC